Navigation Links
Meth exposure in young adults leads to long-term behavioral consequences
Date:8/14/2007

WASHINGTON, DC August 13, 2007 Young adults who use methamphetamine may be more vulnerable to age-related brain degeneration when they grow older, new animal research suggests.

The emergence of behavioral deficits in animals months after methamphetamine discontinuation may be relevant to human methamphetamine abusers, says Nora Volkow, MD, director of the National Institute for Drug Abuse. It suggests that even though their current use may not result in deficits, as they age these deficits will become manifest. Volkow did not participate in the study.

The new work examines the idea that methamphetamine puts young users at risk of developing deficits later in life that are symptomatic of Parkinsons disease in individuals with depletion of glial derived neurotrophic factor (GDNF), a protein that protects and repairs dopamine in areas of the brain related to movement control. Loss of nerve cells that produce dopamine is a major factor in the disease.

In their work, published August 15 in The Journal of Neuroscience, Jacqueline McGinty, PhD, at the Medical University of South Carolina, and her colleagues examined the role of GDNF in mice. At 2.5 months of age, the equivalent of adolescence in humans, mice with a partial GDNF gene deletion were compared to mice without the gene deletion; both were given either methamphetamine or saline injections four times over an eight-hour period. McGintys team discovered that the effects of this methamphetamine binge were exacerbated in the mice with the GDNF deletion. In addition, at 12 months, the GDNF-depleted mice moved significantly less than genetically normal mice treated with methamphetamine.

Methamphetamine intoxication in any young adult may have deleterious consequences later in life, although they may not be apparent until many decades after the exposure, says McGinty. These studies speak directly to the possibility of long-term public health consequences resulting from the current epidemic of methamphetamine abuse among young adults.

Future studies might involve identifying the reasons for increased vulnerability to methamphetamine in GDNF-depleted mice in order to help minimize the harm methamphetamine causes to the brain..


'/>"/>
Contact: Sara Harris
sharris@sfn.org
202-962-4000
Society for Neuroscience
Source:Eurekalert

Related biology news :

1. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
2. Any exposure to tobacco smoke during pregnancy is risky
3. Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers
4. Prenatal exposure to famine increases risk of schizophrenia
5. Prenatal exposure to marine toxin causes lasting damage
6. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
7. Exposure to volcanic mineral associated with increased mesothelioma incidence in Turkey
8. Prenatal nicotine exposure reduces breathing response of newborns...
9. Nicotine exposure during development leads to hearing problems
10. Bird brains shrink from exposure to contaminants
11. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... -- Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion ... at a compound annual growth rate (CAGR) of 24.0% through ... markets for synthetic biology. - Analyses of global market trends, ... compound annual growth rates (CAGRs) through 2021. - Coverage of ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... PHILADELPHIA , Feb. 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immune system to find a better treatment for triple negative ... Start in France program. ... is an accelerator designed to help entrepreneurs grow their business ... was one of eight American companies selected to complete an ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
Breaking Biology Technology: